Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ARQT
ARQT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ARQT News
FDA Sets PDUFA Date for ZORYVE Cream Expansion
3h ago
Newsfilter
Arcutis FDA Accepts Zoryve Label Expansion Application
1h ago
seekingalpha
Arcutis Biotherapeutics' FDA Accepts New Drug Application for ZORYVE Cream
3h ago
NASDAQ.COM
Comparative Analysis of Arcutis and Vertex Biotherapeutics
5d ago
NASDAQ.COM
Investment Comparison: Arcutis vs. Vertex
5d ago
Fool
Arcutis Launches Virtual Health Platform for Dermatology Care
Jun 30 2026
Newsfilter
Arcutis Receives FDA Approval for ZORYVE in Children
Jun 30 2026
NASDAQ.COM
FDA Approves ZORYVE Cream for Children as Young as 2 for Plaque Psoriasis
Jun 29 2026
Newsfilter
Analysis of Arcutis Biotherapeutics Executive Stock Transaction
Jun 24 2026
Fool
Arcutis Director Sells Shares, Limited Impact on Holdings
Jun 24 2026
NASDAQ.COM
Arcutis Biotherapeutics Q1 2026 Earnings Call Insights
May 07 2026
seekingalpha
Arcutis Submits ZORYVE Application for Infant Atopic Dermatitis Treatment
Apr 27 2026
Newsfilter
Arcutis Biotherapeutics Advances ZORYVE in Pediatric Dermatology
Apr 19 2026
Yahoo Finance
Biotech IPOs Show Strong Performance in Q1 2026
Apr 08 2026
Newsfilter
Arcutis Biotherapeutics Executive Sells Shares
Apr 08 2026
Fool
Arcutis Biotherapeutics Director Sells Shares
Apr 08 2026
NASDAQ.COM
Show More News
